Yungjin Pharmaceutical Co., Ltd. (003520)
Market Closed
15 Jun, 06:30
KRX SM KRX SM Primary ₩
1,271. 00
+6
+0.4743%
₩
363.22B Market Cap
- P/E Ratio
- Div Yield
296,971 Volume
- Eps
₩ 1,265
Previous Close Want to track 003520 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 9.47 |
| | | - | 10.5 |
| | | - | 5.46 |
| | | - | 7.62 |
| | | - | 3.37 |
| | | - | 0.93 |
| | | - | 7.14 |
| | | - | 8.15 |
| | | - | 3.95 |
| | | - | 1.19 |
| | | - | - |
| | | - | 25.88 |
| | | - | 9.03 |
| | | - | 20.78 |
| | | - | 10.41 |
| | | - | 7.79 |
003520 Earnings Reports FAQ
What is the earnings per share (EPS) for 003520?
EPS data for 003520 is currently not available, as Yungjin Pharmaceutical Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 6.72%, reflecting the 003520's performance and KRX SM market conditions.
When is the next earnings release date?
Yungjin Pharmaceutical Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Yungjin Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 003520 at this time, as Yungjin Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
